Terms: = Liver cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
136 results:
1. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
[No Abstract] [Full Text] [Related]
2. The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018.
Xiao G; Xu Z; Zhang Y; Dai S; Ouyang G; Huang Y; Liu Y; Cao D; Luo F
Aging (Albany NY); 2024 Mar; 16(5):4204-4223. PubMed ID: 38431305
[TBL] [Abstract] [Full Text] [Related]
3. Causes of death and nomogram for patients with oncologic hepato-biliary-pancreatic disorders: A large-cohort study.
Xu J; Huang S; Yan Q; Jiang J; Hu N; Zhang W; Shi L; Deng M; Tang X; Liao J
Medicine (Baltimore); 2024 Feb; 103(8):e37187. PubMed ID: 38394524
[TBL] [Abstract] [Full Text] [Related]
4. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
Lee S; Shin W; Park DG; Namgung H
Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study.
Fang C; Xu C; Jia X; Li X; Yin C; Xing X; Li W; Wang Z
BMC Gastroenterol; 2024 Jan; 24(1):1. PubMed ID: 38166611
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the efficacy and safety of CalliSpheres® microsphere-transarterial chemoembolization in large hepatocellular carcinoma.
Zhou C; Peng C; Liu F; Xiao J; Li G; Chen C; Shi L; Li H
J Cancer Res Ther; 2023 Dec; 19(6):1575-1581. PubMed ID: 38156924
[TBL] [Abstract] [Full Text] [Related]
7. Development of a nomogram to predict survival in advanced biliary tract cancer.
Imaoka H; Ikeda M; Nomura S; Morizane C; Okusaka T; Ozaka M; Shimizu S; Yamazaki K; Okano N; Sugimori K; Shirakawa H; Mizuno N; Satoi S; Yamaguchi H; Sugimoto R; Gotoh K; Sano K; Asagi A; Nakamura K; Ueno M
Sci Rep; 2023 Dec; 13(1):21548. PubMed ID: 38057434
[TBL] [Abstract] [Full Text] [Related]
8. Association of apc Expression with Its Promoter Methylation Status and the prognosis of Hepatocellular Carcinoma.
Xing W; Li Y; Chen J; Hu Q; Liu P; Ge X; Lv J; Wang D
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3851-3857. PubMed ID: 38019243
[TBL] [Abstract] [Full Text] [Related]
9. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
10. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
[TBL] [Abstract] [Full Text] [Related]
11. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy.
Shao M; Tao Q; Xu Y; Xu Q; Shu Y; Chen Y; Shen J; Zhou Y; Wu Z; Chen M; Yang J; Shi Y; Wen T; Bu H
Chin Med J (Engl); 2023 Sep; 136(17):2066-2076. PubMed ID: 37249521
[TBL] [Abstract] [Full Text] [Related]
12. Exome Sequencing of Paired Colorectal Carcinomas and Synchronous liver Metastases for prognosis and Therapy Prediction.
Hlaváč V; Červenková L; Šůsová S; Holý P; Liška V; Vyčítal O; Šorejs O; Fiala O; Daum O; Souček P
JCO Precis Oncol; 2023 May; 7():e2200557. PubMed ID: 37141551
[TBL] [Abstract] [Full Text] [Related]
13. The significance of peri-neural invasion in patients with gallbladder carcinoma after curative surgery: a 10 year experience in China.
Lv TR; Hu HJ; Liu F; Ma WJ; Jin YW; Li FY
Updates Surg; 2023 Aug; 75(5):1123-1133. PubMed ID: 37099122
[TBL] [Abstract] [Full Text] [Related]
14. Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma.
Wang X; Chen J; Lin L; Li Y; Tao Q; Lang Z; Zheng J; Yu Z
BMC Cancer; 2023 Mar; 23(1):284. PubMed ID: 36978017
[TBL] [Abstract] [Full Text] [Related]
15. High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression.
Zhu P; Pei Y; Yu J; Ding W; Yang Y; Liu F; Liu L; Huang J; Yuan S; Wang Z; Gu F; Pan Z; Chen J; Qiu J; Liu H
PeerJ; 2023; 11():e14891. PubMed ID: 36855431
[TBL] [Abstract] [Full Text] [Related]
16. Recurrence of gastric schwannoma.
Ruiz Pardo J; Sánchez Fuentes PA; García Redondo M; Gras Gómez CM; Vidaña Márquez E; Belda Lozano R; Ferrer-Márquez M; Reina Duarte Á
Rev Esp Enferm Dig; 2023 Apr; 115(4):215-216. PubMed ID: 36719332
[TBL] [Abstract] [Full Text] [Related]
17. Meta-learning algorithm development to predict outcomes in patients with hepatitis C virus-related hepatocellular carcinoma.
Lithy RM; Omar Abdelaziz A; Awad A; Ibrahim Shousha H; Omran D; Mahmoud Nabil M; Hosni Abdelmaksoud A; Mahmoud Elbaz T; Mabrouk M
Arab J Gastroenterol; 2022 Nov; 23(4):230-234. PubMed ID: 36400702
[TBL] [Abstract] [Full Text] [Related]
18. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
BMC Cancer; 2022 Oct; 22(1):1046. PubMed ID: 36199046
[TBL] [Abstract] [Full Text] [Related]
19. Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development.
Fu J; Chen F; Lin Y; Gao J; Chen A; Yang J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):4047-4061. PubMed ID: 36038676
[TBL] [Abstract] [Full Text] [Related]
20. Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma.
Bannangkoon K; Hongsakul K; Tubtawee T; Janjindamai P; Akkakrisee S; Piratvisuth T; Geater A
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00506. PubMed ID: 35905418
[TBL] [Abstract] [Full Text] [Related]
[Next]
